OraSure Technologies - 28 Year Stock Price History | OSUR
Historical daily share price chart and data for OraSure Technologies since 1992 adjusted for splits. The latest closing stock price for OraSure Technologies as of April 07, 2020 is 10.64.
- The all-time high OraSure Technologies stock closing price was 24.88 on December 23, 1994.
- The OraSure Technologies 52-week high stock price is 11.77, which is 10.6% above the current share price.
- The OraSure Technologies 52-week low stock price is 5.23, which is 50.8% below the current share price.
- The average OraSure Technologies stock price for the last 52 weeks is 8.04.
| OraSure Technologies Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2020 | 7.4276 | 7.8900 | 11.5800 | 5.5700 | 10.6400 | 32.50% |
| 2019 | 9.1443 | 11.6700 | 13.0900 | 6.5700 | 8.0300 | -31.25% |
| 2018 | 16.3639 | 19.2900 | 22.0400 | 10.5300 | 11.6800 | -38.07% |
| 2017 | 15.7649 | 8.7900 | 22.8100 | 8.4800 | 18.8600 | 114.81% |
| 2016 | 7.2931 | 6.3500 | 9.3700 | 5.1800 | 8.7800 | 36.34% |
| 2015 | 6.3313 | 9.9500 | 10.5200 | 4.4400 | 6.4400 | -36.49% |
| 2014 | 7.7533 | 6.4700 | 10.5300 | 5.5300 | 10.1400 | 61.21% |
| 2013 | 5.4950 | 7.2500 | 7.3700 | 3.7900 | 6.2900 | -12.40% |
| 2012 | 10.0560 | 9.5100 | 13.3800 | 6.6900 | 7.1800 | -21.19% |
| 2011 | 8.0305 | 6.0100 | 9.9900 | 6.0100 | 9.1100 | 58.43% |
| 2010 | 4.8892 | 5.2900 | 6.7700 | 3.2500 | 5.7500 | 13.19% |
| 2009 | 3.1958 | 3.6600 | 5.1900 | 2.2500 | 5.0800 | 38.04% |
| 2008 | 5.3908 | 8.7200 | 9.1100 | 2.4300 | 3.6800 | -58.61% |
| 2007 | 8.5124 | 8.1500 | 10.5200 | 7.0400 | 8.8900 | 7.63% |
| 2006 | 8.8518 | 9.1200 | 11.5000 | 6.2500 | 8.2600 | -6.35% |
| 2005 | 8.8830 | 6.6000 | 13.9400 | 5.4300 | 8.8200 | 31.25% |
| 2004 | 7.6589 | 7.9200 | 10.5000 | 5.2000 | 6.7200 | -15.58% |
| 2003 | 7.7223 | 5.6400 | 10.7900 | 5.3800 | 7.9600 | 46.06% |
| 2002 | 5.9586 | 12.2000 | 12.2000 | 3.6500 | 5.4500 | -55.14% |
| 2001 | 10.1882 | 7.5310 | 14.7400 | 6.5000 | 12.1500 | 47.27% |
| 2000 | 10.8315 | 6.4400 | 17.0000 | 5.8750 | 8.2500 | 26.92% |
| 1999 | 5.6113 | 6.0000 | 7.8800 | 4.0000 | 6.5000 | 10.73% |
| 1998 | 5.3131 | 5.3800 | 6.8800 | 3.0000 | 5.8700 | 17.40% |
| 1997 | 8.7378 | 12.1200 | 16.2500 | 4.5000 | 5.0000 | -56.52% |
| 1996 | 15.5263 | 15.2500 | 21.5000 | 11.1200 | 11.5000 | -30.30% |
| 1995 | 15.5519 | 21.2500 | 21.2500 | 9.8800 | 16.5000 | -22.83% |
| 1994 | 18.1950 | 20.5000 | 24.8800 | 14.0000 | 21.3800 | 4.91% |
| 1993 | 19.4374 | 19.1200 | 23.6200 | 16.2500 | 20.3800 | 13.22% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.689B | $0.155B |
| OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $145.889B | 25.53 |
| Medtronic (MDT) | Ireland | $126.096B | 16.95 |
| Stryker (SYK) | United States | $62.094B | 20.06 |
| Boston Scientific (BSX) | United States | $45.907B | 20.68 |
| Baxter (BAX) | United States | $43.082B | 26.29 |
| Coloplast (CLPBY) | Denmark | $31.666B | 48.87 |
| Lonza Group Ag (LZAGY) | Switzerland | $30.808B | 0.00 |
| Terumo (TRUMY) | Japan | $25.125B | 0.00 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $24.988B | 0.00 |
| ResMed (RMD) | United States | $22.893B | 39.77 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.215B | 12.44 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.935B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $14.665B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $11.410B | 53.33 |
| Insulet (PODD) | United States | $10.806B | 661.15 |
| William Demant Holdings (WILYY) | Denmark | $7.898B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $7.302B | 21.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $6.994B | 0.00 |
| Perrigo (PRGO) | Ireland | $6.476B | 11.80 |
| GN STORE NORD (GNNDY) | Denmark | $6.057B | 31.29 |
| Haemonetics (HAE) | United States | $5.142B | 31.65 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.020B | 0.00 |
| Canopy Growth (CGC) | Canada | $5.010B | 0.00 |
| ICU Medical (ICUI) | United States | $4.301B | 28.09 |
| Quidel (QDEL) | United States | $4.034B | 35.41 |
| Neogen (NEOG) | United States | $3.598B | 60.95 |
| Agios Pharmaceuticals (AGIO) | United States | $2.706B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $2.677B | 0.00 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $2.438B | 0.00 |
| NuVasive (NUVA) | United States | $2.419B | 18.71 |
| Envista Holdings (NVST) | United States | $2.275B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.476B | 24.86 |
| AtriCure (ATRC) | United States | $1.368B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.302B | 0.00 |
| TG Therapeutics (TGTX) | United States | $1.046B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.986B | 19.50 |
| Aurora Cannabis (ACB) | Canada | $0.973B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.921B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.835B | 17.34 |
| Aphria (APHA) | $0.802B | 0.00 | |
| Cerus (CERS) | United States | $0.788B | 0.00 |
| DFB Healthcare Acquisitions (AHCO) | United States | $0.757B | 136.15 |
| Omeros (OMER) | United States | $0.752B | 0.00 |
| InMode (INMD) | Israel | $0.709B | 0.00 |
| PetIQ (PETQ) | United States | $0.675B | 18.38 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.647B | 38.48 |
| Quanterix (QTRX) | United States | $0.596B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.490B | 27.59 |
| Surmodics (SRDX) | United States | $0.455B | 52.30 |
| Lantheus Holdings (LNTH) | United States | $0.440B | 9.90 |
| Owens & Minor (OMI) | United States | $0.427B | 11.67 |
| Meridian Bioscience (VIVO) | United States | $0.380B | 15.31 |
| Zynex (ZYXI) | United States | $0.371B | 39.96 |
| Vapotherm (VAPO) | United States | $0.367B | 0.00 |
| Repro-Med Systems (KRMD) | United States | $0.337B | 212.50 |
| Utah Medical Products (UTMD) | United States | $0.305B | 21.83 |
| Organigram Holdings (OGI) | Canada | $0.296B | 0.00 |
| MacroGenics (MGNX) | United States | $0.273B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.220B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.210B | 128.63 |
| Female Health (VERU) | United States | $0.203B | 0.00 |
| HEXO (HEXO) | $0.197B | 0.00 | |
| InfuSystems Holdings (INFU) | United States | $0.191B | 159.67 |
| Exagen (XGN) | United States | $0.170B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.169B | 19.13 |
| Rockwell Medical (RMTI) | United States | $0.144B | 0.00 |
| United Health Products (UEEC) | United States | $0.140B | 0.00 |
| Evolus (EOLS) | United States | $0.131B | 0.00 |
| Bovie Medical (APYX) | United States | $0.127B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.111B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.110B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 7.08 |
| Chimerix (CMRX) | United States | $0.086B | 0.00 |
| Brainsway (BWAY) | Israel | $0.082B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.079B | 0.00 |
| United-Guardian (UG) | United States | $0.063B | 13.17 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.062B | 0.00 |
| Nephros (NEPH) | United States | $0.060B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.055B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.054B | 0.00 |
| Surface Oncology (SURF) | United States | $0.049B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.036B | 0.00 |
| ImmuCell (ICCC) | United States | $0.029B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.026B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.024B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.024B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.013B | 0.00 |
| Myomo (MYO) | United States | $0.010B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.010B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.002B | 0.00 |
